Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice.
Treatment and prophylaxis of uncomplicated infections with standard systemic antibiotics are usually successful. However, standard systemic antibiotic therapy alone is frequently unsatisfactory in certain circumstances, such as the presence of a foreign body (FB), necrotic tissue, overwhelming bacte...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1995
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486914/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1752 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|